ERBB2 and neoplasm: In the index tumour, the number of luminal A, luminal B/HER2-negative, luminal B/HER2-positive, HER2-positive, and triple-negative subtypes was 5 (24%), 7 (33%), 3 (14%), 5 (24%), and 1 (5%), respectively.